Stocks in play: BriaCell Therapeutics Corp.
Will be presenting preclinical Bria-OTS+ data at a poster presentation at the Society for Immunotherapy of Cancer (SITC) 40th Anniversary Annual Meeting, held November 7-9, in National Harbor, MD. BriaCell Therapeutics Corp. shares T.BCT are trading unchanged at $17.80.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.